Venous Thromboembolism in Plastic Surgery Patients | Journal CME Article-Journal CME Article: Venous Thromboembolism in Plastic Surgery Patients

Journal CME Article: Venous Thromboembolism in Plastic Surgery Patients

Pdf Summary

This CME review addresses venous thromboembolism (VTE)—deep vein thrombosis (DVT) and pulmonary embolism (PE)—as a major patient-safety issue in plastic surgery. PE is the leading cause of death after ambulatory and inpatient plastic surgery and can cause rapid cardiovascular collapse, sudden death, long-term cardiopulmonary limitations, and high recurrence risk. DVT requires therapeutic anticoagulation with bleeding risk and can lead to post-thrombotic syndrome. Because consequences are significant, prevention is emphasized.

The article presents a practical framework for perioperative management across preoperative, intraoperative, and postoperative phases: <strong>risk identification, risk modification, and risk reduction</strong>. For <strong>risk identification</strong>, the authors highlight the <strong>2005 Caprini score</strong> as the best-supported and plastic-surgery–validated tool for patient-centric VTE assessment. Caprini scores correlate with stepwise increases in postoperative VTE risk and help guide informed consent and prophylaxis decisions; however, the score is a “jumping off point” and must be combined with clinical judgment and patient risk tolerance. Selected patients (e.g., strong family history, unexplained prior VTE, recurrent pregnancy loss) may warrant hypercoagulability evaluation or hematology referral.

<strong>Risk modification</strong> focuses on addressing modifiable factors such as nicotine use (recommend cessation 4–6 weeks pre-op), elevated BMI (optimize when feasible), perioperative estrogen management (individualized due to tradeoffs; risk normalizes ~3–4 weeks after stopping), timing after infection/recent surgery (often wait ~1 month), varicose veins, operative duration, and combining multiple procedures. Destination surgery/air travel may increase asymptomatic DVT risk; compression stockings can help but may be impractical postoperatively.

<strong>Risk reduction</strong> includes technique and systems strategies: consider non-general anesthesia when appropriate, minimize operating time (with “pop-off” plans), routine sequential compression devices, hydration and early ambulation, and selective use of chemoprophylaxis. For inpatients, evidence suggests prophylactic anticoagulation benefits mainly those with <strong>Caprini ≥7</strong>, balanced against increased bleeding/hematoma risk; enoxaparin (often twice daily) is most studied. Routine post-discharge anticoagulation after DIEP reconstruction shows inconsistent benefit. For most aesthetic/outpatient patients, baseline VTE risk is very low and blanket anticoagulation can increase bleeding; targeted prophylaxis is recommended. Routine screening ultrasound for asymptomatic DVT lacks guideline support and may lead to more intensive treatment burdens.

Overall, a thoughtful, individualized approach can reduce—but never eliminate—VTE risk in plastic surgery.

Keywords

venous thromboembolism (VTE)

deep vein thrombosis (DVT)

pulmonary embolism (PE)

plastic surgery patient safety

perioperative VTE prophylaxis

2005 Caprini score

risk stratification and clinical judgment

chemoprophylaxis (enoxaparin)

sequential compression devices and early ambulation

bleeding and hematoma risk